Cuting-edge Surgical Research (ongoing)

Posted On 2020-12-16 16:27:10



This series on Cuting-edge Surgical Research (ongoing) is edited by Dr. Masakazu Toi, MD, PhD from Breast Cancer Unit, Kyoto University Hospital, Kyoto University, Japan.

Masakazu Toi, MD, PhD
Breast Cancer Unit, Kyoto University Hospital, Kyoto University, Japan

Dr. Masakazu Toi graduated in 1982 from Hiroshima University School of Medicine with his Medical Doctorate and in 1988 with his Ph.D. He studied on tumor angiogenesis at the Institute of Molecular Medicine of Oxford University, UK from 1990 to 1992. He was appointed to the Department of Clinical Oncology, John-Radcliffe Hospital of Oxford University as an academic visitor as well. From 1992 to 2007, Dr. Toi worked for Tokyo Metropolitan Cancer and Infectious Disease Center. He was appointed to a director of Surgery and also to a director of Clinical Trial Department. He was engaged in the care of breast cancer patients, laboratory researches and clinical trials. In 2000, he studied at Department of Breast Medical Oncology, Dana-Farber Cancer Institute of Harvard University as a Yamagiwa-Yoshida fellow. Dr. Toi has been appointed to be a visiting professor of Drug Delivery System Center, Tokyo Science University. Since 2007 Dr. Toi has been appointed to Professor of Breast Surgery at the Graduate School of Medicine, Kyoto University, Japan and Director of the Breast Cancer Unit, Kyoto University Hospital.

Dr. Toi is involved in various innovative research projects on the development of new diagnostics and therapeutics. He serves as an editorial board member of multiple academic journals and has authored or co-authored over 450 articles. He has been appointed to Deputy Director of the Society-Academia Collaboration for Innovation of Kyoto University from 2016.

Series outline:

  1. Introduction of the whole issue 
  2. Artificial intelligence for breast cancer 
  3. Surgical therapy for metastatic breast cancer
  4. Adjuvant therapy for elderly breast cancer patients
  5. Trends in nipple sparing amstectomy and breast reconstruction
  6. Multitracer sentinel node biopsy after neoadjuvant therapy
  7. New quantitative assay for biomarkers
  8. Subtype change by neoadjuvant therapy

Disclosure:
The series “Cuting-edge Surgical Research (ongoing)” was commissioned by the editorial office, Annals of Breast Surgery without any sponsorship or funding. Dr. Masakazu Toi is serving as the unpaid Guest Editor for the series.